David Whitcombe
Fondatore presso DxS Ltd.
Profilo
David is a Venture Partner with Catapult’s GM&C Life Sciences Fund, where he assesses investment opportunities and works with the Fund’s smaller investments to help companies successfully grow.
David is a well-known consultant and non-executive director/Chairman who co-founded DxS Diagnostics in 2000 to exploit a personalised medicine technology he had invented while with AstraZeneca Diagnostics.
DxS was sold to Qiagen in September 2009 for in excess of £100m.
Prior to DxS, David was Head of Technology Development at AstraZenica Diagnostics for four years where he led a team of up to 15 scientists working on new genome technologies.
David began his career as a Post-Doctoral Fellow with Warwick University Department of Biological Sciences, before joining Cambridge University Department of Medicine as a Senior Post-Doctoral Fellow where he researched the Genetics of Human Disease for six years.
David holds a First Class BSc in Genetics from the University of York and PhD in Biochemistry/Molecular Biology from the University of Leicester.
Posizioni attive di David Whitcombe
| Società | Posizione | Inizio |
|---|---|---|
DxS Ltd.
 DxS Ltd. Medical SpecialtiesHealth Technology DxS Ltd. is a personalized medicine company which engages in the development and manufacture of companion diagnostic products. Its products make use of molecular diagnostics to aid doctors and drug companies in selecting therapies for patients. It offers its products, technology, and services to the healthcare industry to enable the delivery of safe and effective medicines. The company was founded by David Whitcombe in 2001 is headquartered in Manchester, the United Kingdom. | Fondatore | 22/09/2009 |
Cytox Ltd.
 Cytox Ltd. Medical DistributorsDistribution Services Cytox Ltd. develops products and services for neurodegenerative disorders. It develops cellular and genetic assays for Alzheimer’s disease diagnosis. The firm offers biomarker services to pharmaceutical companies conducting clinical trials with drugs for the treatment of AD and mild cognitive impairment; and drug-screening services. The company was founded by Zsuzsanna Nagy, Margaret Esiri, Roy Bicknell and James S. Chadwick in 2004 and is headquartered in Oxford, the United Kingdom. | Direttore/Membro del Consiglio | - |
Catapult Ultimate Holdings Ltd.
 Catapult Ultimate Holdings Ltd. Investment ManagersFinance Catapult Ultimate Holdings Ltd (Catapult Ultimate Holdings) is an independent venture capital firm founded in 1999. The firm is headquartered in Leicester, United Kingdom. | Investitore di Private Equity | - |
Destina Genomics Ltd.
 Destina Genomics Ltd. BiotechnologyHealth Technology Destina Genomics Ltd. is engaged in development of molecular diagnostic products. Its products include pipeline assay kits and liverace. The company was founded by Hugh Llyine, Juan J. Diaz-Mochon and Mark Bradley in 2011 and is headquartered in Edinburgh, the United Kingdom. | Presidente | 01/09/2015 |
Precedenti posizioni note di David Whitcombe
| Società | Posizione | Fine |
|---|---|---|
Biofortuna Ltd.
 Biofortuna Ltd. Medical SpecialtiesHealth Technology Biofortuna Ltd. provides molecular diagnostic solutions. Its products include SSPGo and ReadyPlex. The firm offers design and development, freeze-drying, manufacturing and dispensing and kitting services. The firm offers its technology on a custom service basis to clients from the clinical, veterinary, food, and research sectors. The company was founded by Mike Bunce, Ben Passey and David Charvill in 2008 and is headquartered in Wirral, the United Kingdom. | Direttore/Membro del Consiglio | - |
NanoFlex Ltd.
 NanoFlex Ltd. Electrical ProductsProducer Manufacturing NanoFlex Ltd. designs and manufactures electrochemical electrodes. Its products serve applications in process control, environmental sensing, energy storage and electro synthesis. The company was founded by Neville John Freeman and Amiel Marjorie Farrington in 2008 and is headquartered in Daresbury, the United Kingdom. | Direttore/Membro del Consiglio | - |
| AstraZeneca Diagnostics | Corporate Officer/Principal | - |
Formazione di David Whitcombe
| The University of York | Undergraduate Degree |
| University of Leicester | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
Cytox Ltd.
Cytox Ltd. Medical DistributorsDistribution Services Cytox Ltd. develops products and services for neurodegenerative disorders. It develops cellular and genetic assays for Alzheimer’s disease diagnosis. The firm offers biomarker services to pharmaceutical companies conducting clinical trials with drugs for the treatment of AD and mild cognitive impairment; and drug-screening services. The company was founded by Zsuzsanna Nagy, Margaret Esiri, Roy Bicknell and James S. Chadwick in 2004 and is headquartered in Oxford, the United Kingdom. | Distribution Services |
DxS Ltd.
DxS Ltd. Medical SpecialtiesHealth Technology DxS Ltd. is a personalized medicine company which engages in the development and manufacture of companion diagnostic products. Its products make use of molecular diagnostics to aid doctors and drug companies in selecting therapies for patients. It offers its products, technology, and services to the healthcare industry to enable the delivery of safe and effective medicines. The company was founded by David Whitcombe in 2001 is headquartered in Manchester, the United Kingdom. | Health Technology |
| AstraZeneca Diagnostics | |
Biofortuna Ltd.
Biofortuna Ltd. Medical SpecialtiesHealth Technology Biofortuna Ltd. provides molecular diagnostic solutions. Its products include SSPGo and ReadyPlex. The firm offers design and development, freeze-drying, manufacturing and dispensing and kitting services. The firm offers its technology on a custom service basis to clients from the clinical, veterinary, food, and research sectors. The company was founded by Mike Bunce, Ben Passey and David Charvill in 2008 and is headquartered in Wirral, the United Kingdom. | Health Technology |
NanoFlex Ltd.
NanoFlex Ltd. Electrical ProductsProducer Manufacturing NanoFlex Ltd. designs and manufactures electrochemical electrodes. Its products serve applications in process control, environmental sensing, energy storage and electro synthesis. The company was founded by Neville John Freeman and Amiel Marjorie Farrington in 2008 and is headquartered in Daresbury, the United Kingdom. | Producer Manufacturing |
Catapult Ultimate Holdings Ltd.
Catapult Ultimate Holdings Ltd. Investment ManagersFinance Catapult Ultimate Holdings Ltd (Catapult Ultimate Holdings) is an independent venture capital firm founded in 1999. The firm is headquartered in Leicester, United Kingdom. | Finance |
Destina Genomics Ltd.
Destina Genomics Ltd. BiotechnologyHealth Technology Destina Genomics Ltd. is engaged in development of molecular diagnostic products. Its products include pipeline assay kits and liverace. The company was founded by Hugh Llyine, Juan J. Diaz-Mochon and Mark Bradley in 2011 and is headquartered in Edinburgh, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- David Whitcombe
